Market Snapshot
S&P Futures
3,779.5
Dow Futures
30,569
Nasdaq Futures
11,622.75
Black Diamond Therapeutics, Inc.
(NASDAQ:BDTX)
$2.64
$0.02
0.76%
Black Diamond Therapeutics, Inc. Chart
BDTX Stock Price Today
Black Diamond Therapeutics, Inc. (BDTX) stock rallied over 0.76% intraday to trade at $2.64 a share on NASDAQ. The stock opened with a gain of 7.76% at $2.5 and touched an intraday high of $2.67, rising 7.32% against the last close of $2.46. The stock went to a low of $2.48 during the session.
Stock Snapshot
$2.46
Prev. Close
89.29 Million
Market Cap
$2.48
Day Low
$2.5
Open
36.27 Million
Number of Shares
$2.67
Day High
-
P/E ratio
-3.33
EPS (TTM)
5.78
Cash Flow per Share
9.13
Free Float in %
6.04
Book Value
136,225
Volume
Black Diamond Therapeutics, Inc. Historical Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| 2022-07-01 | $2.5 | $2.67 | $2.48 | $2.62 | 111,600 |
| 2022-06-30 | $2.45 | $2.51 | $2.32 | $2.46 | 122,800 |
| 2022-06-29 | $2.44 | $2.57 | $2.33 | $2.47 | 212,200 |
| 2022-06-28 | $2.35 | $2.49 | $2.28 | $2.44 | 222,200 |
| 2022-06-27 | $2.26 | $2.38 | $2.1 | $2.35 | 138,700 |
| 2022-06-24 | $2.26 | $2.45 | $2.15 | $2.27 | 2,953,100 |
| 2022-06-23 | $2.21 | $2.32 | $2.17 | $2.2 | 342,900 |
| 2022-06-22 | $2.01 | $2.2 | $2.01 | $2.17 | 241,700 |
| 2022-06-21 | $2.08 | $2.18 | $2.04 | $2.07 | 167,600 |
| 2022-06-17 | $2.01 | $2.18 | $1.96 | $2.01 | 159,800 |
Contact Details
Company Information
Employees-
Beta-
Sales or Revenue0
5Y Sales Change-
Fiscal Year Ends2021-12-30
SectorHealth Care
IndustryBiotechnology
About Company
Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 driver mutations. The company is also developing BDTX-1535, a brain-penetrant inhibitor of EGFR mutations, including canonical, intrinsic resistance, and acquired resistance mutations; and BDTX-4933, a brain-penetrant inhibitor of oncogenic BRAF class I, II and III alterations. It has a strategic partnership with OpenEye Scientific Software, Inc. The company was formerly known as ASET Therapeutics, Inc. and changed its name to Black Diamond Therapeutics, Inc. in January 2018. Black Diamond Therapeutics, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.
Frequently Asked Questions
What is the current Black Diamond Therapeutics, Inc. (BDTX) stock price?
Black Diamond Therapeutics, Inc. (NASDAQ: BDTX) stock price is $2.64 as of the last check on Friday, July 1. During the trading session, BDTX stock reached the peak price of $2.67 while $2.48 was the lowest point it dropped to.
BDTX's industry and sector of operation?
The NASDAQ listed BDTX is part of Biotechnology industry that operates in the broader Health Care sector. Black Diamond Therapeutics, Inc. , a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors.
Who are the executives of BDTX?
Dr. David M. Epstein Ph.D.
Co-Founder, Pres, CEO & Director
Mr. Brent Hatzis-Schoch Esq., J.D.
COO & Gen. Counsel
Dr. Elizabeth Buck Ph.D.
Co-Founder & Chief Scientific Officer
Dr. Fang Ni Pharm.D.
CFO, Principal Financial Officer and Chief Bus. Officer
What is the BDTX stock price today?
BDTX stock traded closed the last session at $2.62, which is $0.02 or 0.76% lower than its previous close of $2.46. BDTX's current trading price is 80.82% lower than its 52-week high of $12.48 where as its distance from 52-week low of 1.46% is -78.85%.
How many employees does BDTX have?
Number of BDTX employees currently stands at -. BDTX operates from One Main Street, 10th Floor, Cambridge, MA 02142, United States.
Link for BDTX official website?
Official Webiste of $BDTX is: https://www.blackdiamondtherapeutics.com
How do I contact BDTX?
BDTX could be contacted at BDTX operates from One Main Street, 10th Floor, Cambridge, MA 02142, United States, or at phone #617 252 0848 and can also be accessed through its website.
How many shares of BDTX are traded daily?
BDTX stock volume for the day was 136,225 shares while in the previous session number of BDTX shares traded was 111,600 . The average number of BDTX shares traded daily for last 3 months was 282.57 Thousands.
How much did BDTX change today?
The percentage change in BDTX stock occurred in the recent session was 0.76% while the dollar amount for the price change in BDTX stock was $0.02.
What price range BDTX stock been trading in?
In the recent session, the day high for BDTX stock was $2.67 while the low for BDTX stock touched on the day was $2.48.
What is the market cap of BDTX currently?
The market value of BDTX currently stands at 89.29 Million with its latest stock price at $2.64 and 36.27 Million of its shares outstanding.